The Rising Tide of Allergy
Allergic diseases — allergic rhinitis, asthma, food allergy, and eczema — have risen dramatically over recent decades, particularly in industrialized nations. The hygiene hypothesis and its refinements suggest that reduced early-life microbial exposure alters immune development toward allergic responses. Whatever the cause, allergy now affects a substantial share of the population, and management has advanced well beyond simply enduring symptoms or taking antihistamines.
The Treatment Ladder
Modern allergy management follows a stepwise approach. Allergen avoidance, where feasible, is first-line. For allergic rhinitis, intranasal corticosteroids are the most effective single class, outperforming oral antihistamines for nasal symptoms, while second-generation antihistamines control itch and sneezing without the sedation of older agents. Combination therapies address more severe disease. For allergic asthma and severe cases, biologic medications targeting specific immune pathways (such as anti-IgE and anti-IL-5 agents) have transformed outcomes for patients who previously had few options.
Immunotherapy: Modifying the Disease
Allergen immunotherapy is unique in actually modifying the underlying allergic disease rather than just suppressing symptoms. By exposing the immune system to gradually increasing allergen doses — via subcutaneous injections (allergy shots) or sublingual tablets and drops — it induces tolerance that can persist years after treatment ends. It is the only treatment shown to potentially prevent progression from allergic rhinitis to asthma and to reduce new sensitizations. Sublingual options have made immunotherapy more accessible and safer. Facilities managing allergic disease can source diagnostic equipment and patient care supplies through our catalog.
